Pzena Investment Management LLC Takes Position in CVS Health Corporation $CVS

Pzena Investment Management LLC acquired a new position in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 11,769,536 shares of the pharmacy operator’s stock, valued at approximately $1,217,558,000. CVS Health comprises 3.6% of Pzena Investment Management LLC’s investment portfolio, making the stock its 4th biggest holding. Pzena Investment Management LLC owned about 0.92% of CVS Health as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Handelsbanken Fonder AB lifted its stake in shares of CVS Health by 83.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock valued at $112,729,000 after purchasing an additional 496,124 shares during the period. State Street Corp boosted its position in CVS Health by 2.1% during the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after purchasing an additional 1,245,457 shares in the last quarter. Legal & General Group Plc grew its holdings in CVS Health by 0.3% in the fourth quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock valued at $738,777,000 after purchasing an additional 31,249 shares during the period. Deutsche Bank AG increased its position in shares of CVS Health by 28.4% in the fourth quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock valued at $370,333,000 after buying an additional 1,031,998 shares in the last quarter. Finally, Hussman Strategic Advisors Inc. acquired a new position in shares of CVS Health during the 4th quarter worth approximately $3,333,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, Director Larry Robbins sold 1,018,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $93.82, for a total value of $95,508,760.00. Following the transaction, the director directly owned 5,195,261 shares of the company’s stock, valued at $487,419,387.02. This trade represents a 16.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.85% of the stock is owned by company insiders.

CVS Health Trading Down 3.3%

Shares of CVS opened at $93.99 on Tuesday. CVS Health Corporation has a 52-week low of $69.40 and a 52-week high of $110.68. The stock has a market cap of $120.21 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. The firm’s fifty day moving average is $102.46 and its two-hundred day moving average is $88.41. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s dividend payout ratio is presently 70.37%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CVS. Wall Street Zen upgraded CVS Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Wells Fargo & Company upped their price objective on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Bank of America increased their price objective on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. Finally, Sanford C. Bernstein boosted their price objective on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 12th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $106.75.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.